Impact of drug treatment history on comparative effectiveness research in schizophrenia

Value in Health

Volumn 14, Issue 5, 2011, Pages 679-686

  McCombs, Jeffrey ^a   Zolfaghari, Sara ^a   Ganapathy, Vaidynathan ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

comparative effectiveness research; schizophrenia; treatment history

Indexed keywords

ANTIDEPRESSANT AGENT; ARIPIPRAZOLE; HALOPERIDOL; MOOD STABILIZER; NEUROLEPTIC AGENT; OLANZAPINE; QUETIAPINE; RISPERIDONE; ZIPRASIDONE;

ADOLESCENT; ADULT; AGED; ALTERNATIVE MEDICINE; ARTICLE; BILLING AND CLAIMS; CHILD; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; PRIORITY JOURNAL; SCHIZOPHRENIA; SCHOOL CHILD; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AFFECT; AGED; ANTIDEPRESSIVE AGENTS; ANTIPSYCHOTIC AGENTS; CHILD; COMPARATIVE EFFECTIVENESS RESEARCH; COST-BENEFIT ANALYSIS; DRUG COSTS; DRUG SUBSTITUTION; DRUG THERAPY, COMBINATION; FEMALE; HEALTH CARE COSTS; HUMANS; LEAST-SQUARES ANALYSIS; LOGISTIC MODELS; MALE; MIDDLE AGED; MODELS, ECONOMIC; OUTCOME AND PROCESS ASSESSMENT (HEALTH CARE); PROPORTIONAL HAZARDS MODELS; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; TIME FACTORS; TREATMENT OUTCOME; UNITED STATES; YOUNG ADULT;

EID: 80052463446     PISSN: 10983015     EISSN: 15244733     Source Type: Journal    
DOI: 10.1016/j.jval.2011.02.002     Document Type: Article

References (10)

1. L. Chen, J.S. McCombs, and J.X. Park The impact of atypical antipsychotic medications on the use of health care by patients with schizophrenia Value Health 11 2008 34 43 (Pubitemid 351160874)
2. L. Chen, J.S. McCombs, and J.X. Park Duration of antipsychotic drug therapy in real world practice: a comparison with CATIE trial results Value Health 11 2008 487 496 (Pubitemid 351712975)
3. K.L. Rascati, M.T. Johnsrud, and M.L. Crismon Olanzapine versus risperidone in the treatment of schizophrenia: a comparison of costs among Texas Medicaid patients Pharmacoeconomics 21 2003 683 697 (Pubitemid 36920634)
4. P.J. Gibson, R. Damler, and E.A. Jackson The impact of olanzapine, risperidone, or haloperidol on the cost of schizophrenia care in a Medicaid population Value Health 7 2004 22 35 (Pubitemid 38186282)
5. A.P. Yu, and R. Ben-Hamadi Comparing the treatment patterns of patients with schizophrenia treated with olanzapine and quetiapine in the Pennsylvania Medicaid population Curr Med Res Opin 25 2009 755 764
6. J.A. Lieberman, T.S. Stroup, and J.P. McEvoy Effectiveness of antipsychotic drugs in patients with chronic schizophrenia N Engl J Med 353 2005 1209 1223 (Pubitemid 41345943)
7. T.S. Stroup, J.A. Lieberman, and J.P. McEvoy Effectiveness of olanzapine, quetiapine, risperidone and ziprasidone in patients with chronic schizophrenia following discontinuation of a previous atypical antipsychotic Am J Psychiatry 163 2006 611 622 (Pubitemid 44464570)
8. T.S. Marshall, J.S. McCombs, and D. Stafkey-Mailey Impact of patient selection criteria and treatment history on comparisons of alternative therapies: a case study of atypical antipsychotics Value Health 12 2009 473 480
9. P.J. Weiden, C. Kozma, A. Grogg, and J. Locklear Partial compliance and risk of rehospitalization among California Medicaid patients with schizophrenia Psychiatr Serv 55 2004 886 891 (Pubitemid 39025215)
10. H. White A heteroscedasticity-consistent matrix estimator and a direct test for heteroscedasticity Econometrica 48 1980 817 838